Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial

NCT05689229 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Secondary Bacterial Infection in COVID-19 Patients

Interventions

DRUG: Colistin

Sponsor

Beni-Suef University